The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies

Journal of Autoimmunity

Volumn 75, Issue , 2016, Pages 118-129

  Bhattarai, Salyan ^a   Ghannam, Khetam ^a   Krause, Sabine ^b   Benveniste, Olivier ^c   Marg, Andreas ^a   de Bruin, Gerjan ^d   Xin, Bo Tao ^d   Overkleeft, Hermen S ^d   Spuler, Simone ^a   Stenzel, Werner ^a   Feist, Eugen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Antigen presentation; Idiopathic inflammatory myopathies; Immunoproteasome subunits; Myokine; Proteasome

Indexed keywords

CD68 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; IMMUNOPROTEASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEASOME; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; PROTEIN SUBUNIT;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOMYOSITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INCLUSION BODY MYOSITIS; INFLAMMATORY INFILTRATE; MACROPHAGE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; PATHOGENESIS; PRIORITY JOURNAL; SKELETAL MUSCLE; SKELETAL MYOBLAST; UPREGULATION; ACUTE HEMORRHAGIC PANCREATITIS; ADULT; AGED; CELL CULTURE; DRUG EFFECTS; FEMALE; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MYOBLAST; PATHOLOGY; PRESCHOOL CHILD; PROTEIN SUBUNIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELLS, CULTURED; CHILD, PRESCHOOL; CYTOKINES; DERMATOMYOSITIS; FEMALE; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-GAMMA; MALE; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; MYOBLASTS; MYOSITIS; PANCREATITIS, ACUTE NECROTIZING; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84994469260     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.08.004     Document Type: Article

References (55)

1. [1] Dimachkie, M.M., Barohn, R.J., Amato, A.A., Idiopathic inflammatory myopathies. Neurol. Clin. 32 (2014), 595–628.
2. [2] Rayavarapu, S., Coley, W., Kinder, T.B., Nagaraju, K., Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skelet. Muscle 3 (2013), 1–13.
3. [3] Dalakas, M.C., Review: an update on inflammatory and autoimmune myopathies. Neuropathol. Appl. Neurobiol. 37 (2011), 226–242.
4. [4] De Paepe, B., Creus, K.K., De Bleecker, J.L., Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 21 (2009), 610–616.
5. [5] Schmidt, J., Barthel, K., Wrede, A., Salajegheh, M., Bähr, M., Dalakas, M.C., Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle. Brain 131 (2008), 1228–1240.
6. [6] Preuße, C., Goebel, H.H., Held, J., Wengert, O., Scheibe, F., Irlbacher, K., et al. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am. J. Pathol. 181 (2012), 2161–2171.
7. [7] Villanova, M., Kawai, M., Lübke, U., Oh, S.J., Perry, G., Six, J., et al. Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers. Brain Res. 603 (1993), 343–347.
8. [8] Pestronk, A., Acquired immune and inflammatory myopathies: pathologic classification. Curr. Opin. Rheumatol. 23 (2011), 595–604.
9. [9] Aouizerate, J., De Antonio, M., Bassez, G., Gherardi, R.K., Berenbaum, F., Guillevin, L., et al. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol. Commun. 2 (2014), 1–8.
10. [10] Vattemi, G., Mirabella, M., Guglielmi, V., Lucchini, M., Tomelleri, G., Ghirardello, A., et al. Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis. Autoimmun. Highlights 5 (2014), 77–85.
11. [11] van der Pas, J., Hengstman, G.J.D., ter Laak, H.J., Borm, G.F., van Engelen, B.G.M., Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. Journal of Neurology. Neurosurg. Psychiatry 75 (2004), 136–139.
12. [12] Fréret, M., Drouot, L., Obry, A., Ahmed-Lacheheb, S., Dauly, C., Adriouch, S., et al. Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response. Am. J. Pathol. 183 (2013), 893–904.
13. [13] Nagaraju, K., Casciola-Rosen, L., Lundberg, I., Rawat, R., Cutting, S., Thapliyal, R., et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis & Rheum. 52 (2005), 1824–1835.
14. [14] Ferrington, D.A., Gregerson, D.S., Chapter 3-Immunoproteasomes: structure, function, and antigen presentation. Tilman, G., (eds.) Progress in Molecular Biology and Translational Science, 2012, Academic Press, 75–112.
15. [15] Orre, M., Kamphuis, W., Dooves, S., Kooijman, L., Chan, E.T., Kirk, C.J., et al. Reactive glia show increased immunoproteasome activity in Alzheimer's disease. Brain 136 (2013), 1415–1431.
16. [16] Niewerth, D., Kaspers, G.J., Assaraf, Y.G., van Meerloo, J., Kirk, C.J., Anderl, J., et al. Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines. J. Hematol. Oncol. 7 (2014), 1–15.
17. [17] Seifert, U., Bialy, L.P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schröter, F., et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142 (2010), 613–624.
18. [18] Muchamuel, T., Basler, M., Aujay, M.A., Suzuki, E., Kalim, K.W., Lauer, C., et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat. Med. 15 (2009), 781–787.
19. [19] Ghannam, K., Martinez-Gamboa, L., Spengler, L., Krause, S., Smiljanovic, B., Bonin, M., et al. Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-Cells and IFN?. PLoS One, 9, 2014, e104048.
20. [20] Hoogendijk, J.E., Amato, A.A., Lecky, B.R., Choy, E.H., Lundberg, I.E., Rose, M.R., et al. 1 19th ENMC International Workshop: Trial Design in Adult Idiopathic Inflammatory Myopathies, with the Exception of Inclusion Body Myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscular Disorders, 14, 2003, 337–345.
21. [21] Schoewel, V., Marg, A., Kunz, S., Overkamp, T., Siegert Carrazedo, R., Zacharias, U., et al. Dysferlin-peptides reallocate mutated dysferlin thereby restoring function. PLoS One, 7, 2012, e49603.
22. [22] de Bruin, G., Huber, E.M., Xin, B.-T., van Rooden, E.J., Al-Ayed, K., Kim, K.-B., et al. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes. J. Med. Chem. 57 (2014), 6197–6209.
23. [23] de Bruin, G., Xin, B.T., Kraus, M., van der Stelt, M., van der Marel, G.A., Kisselev, A.F., et al. A set of activity-based probes to visualize human (Immuno)proteasome activities. Angew. Chem. Int. Ed., 2016, 4199–4203.
24. [24] Meyer Zu Horste, G., Heidenreich, H., Lehmann, H.C., Ferrone, S., Hartung, H.-P., Wiendl, H., et al. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia 58 (2010), 80–92.
25. [25] Moran, E.M., Mastaglia, F.L., Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin. Exp. Immunol. 178 (2014), 405–415.
26. [26] Preuße C., Goebel H.H., Held J., Wengert O., Scheibe F., Irlbacher K. et al. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am. J. Pathol.;181:2161–2171.
27. [27] Qureshi, N., Perera, P.-Y., Shen, J., Zhang, G., Lenschat, A., Splitter, G., et al. The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J. Immunol. 171 (2003), 1515–1525.
28. [28] Brehm, A., Krüger, E., Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases. Semin. Immunopathol. 37 (2015), 323–333.
29. [29] Ferrer, I., Martín, B., Castaño, J.G., Lucas, J.J., Moreno, D., Olivé, M., Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J. Neuropathol. Exp. Neurol. 63 (2004), 484–498.
30. [30] Fratta, P., Engel, W.K., McFerrin, J., Davies, K.J.A., Lin, S.W., Askanas, V., Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-β precursor protein-overexpressing cultured human muscle fibers. Am. J. Pathol. 167 (2005), 517–526.
31. [31] Kitajima, Y., Tashiro, Y., Suzuki, N., Warita, H., Kato, M., Tateyama, M., et al. Proteasome dysfunction induces muscle growth defects and protein aggregation. J. Cell Sci. 127 (2014), 5204–5217.
32. [32] Caudill, C.M., Jayarapu, K., Elenich, L., Monaco, J.J., Colbert, R.A., Griffin, T.A., T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 176 (2006), 4075–4082.
33. + T-cells That lack proteasome immunosubunit expression, in a T-cell Transfer-based colitis model. PLoS One, 9, 2014, e95378.
34. [34] D'Souza, A.J., Desai, S.D., Rudner, X.L., Kelly, M.N., Ruan, S., Shellito, J.E., Suppression of the macrophage proteasome by ethanol impairs MHC class I antigen processing and presentation. PLoS One, 8, 2013, e56890.
35. [35] Naujokat, C., Berges, C., Höh, A., Wieczorek, H., Fuchs, D., Ovens, J., et al. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Immunology 120 (2007), 120–132.
36. [36] Eleftheriadis, T., Pissas, G., Antoniadi, G., Liakopoulos, V., Stefanidis, I., CD8+ T-cell auto-reactivity is dependent on the expression of the immunoproteasome subunit LMP7 in exposed to lipopolysaccharide antigen presenting cells and epithelial target cells. Autoimmunity 46 (2013), 439–445.
37. [37] McCarthy, M.K., Weinberg, J.B., The immunoproteasome and viral infection: a complex regulator of inflammation. Front. Microbiol., 6, 2015.
38. [38] Ivanidze, J., Hoffmann, R., Lochmuller, H., Engel, A.G., Hohlfeld, R., Dornmair, K., Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers. Am. J. Pathol., 179, 2011.
39. [39] Loell, I., Raouf, J., Chen, Y.-W., Shi, R., Nennesmo, I., Alexanderson, H., et al. Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents. Arthritis Res. Ther. 18 (2016), 1–13.
40. [40] Shin E-C, Seifert U, Kato T, Rice CM, Feinstone SM, Kloetzel P-M, et al. Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. The Journal of Clinical Investigation;116:3006–14.
41. [41] Keller, I.E., Vosyka, O., Takenaka, S., Kloß, A., Dahlmann, B., Willems, L.I., et al. Regulation of immunoproteasome function in the lung. Sci. Rep., 5, 2015, 10230.
42. [42] Graça, C.R., Kouyoumdjian, J.A., MHC class I antigens, CD4 and CD8 expressions in polymyositis and dermatomyositis. Rev. Bras. Reumatol. (English Ed. 55 (2015), 203–208.
43. [43] Nagaraju, K., Raben, N., Loeffler, L., Parker, T., Rochon, P.J., Lee, E., et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc. Natl. Acad. Sci. 97 (2000), 9209–9214.
44. [44] CK-c, Li, Knopp, P., Moncrieffe, H., Singh, B., Shah, S., Nagaraju, K., et al. Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis. Am. J. Pathol. 175 (2009), 1030–1040.
45. [45] Goebels, N., Michaelis, D., Wekerle, H., Hohlfeld, R., Human myoblasts as antigen-presenting cells. J. Immunol. 149 (1992), 661–667.
46. [46] Nagaraju, Raben, Merritt, Loeffler, Kirk, Plotz, A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin. Exp. Immunol. 113 (1998), 407–414.
47. [47] Michaelis, Dorothea, G, N., H, R., Constitutive and cytokine-lnduced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am. J. Pathol., 143, 1993, 8.
48. [48] Fehling, H., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U., et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265 (1994), 1234–1237.
49. [49] Basler, M., Dajee, M., Moll, C., Groettrup, M., Kirk, C.J., Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. J. Immunol. 185 (2010), 634–641.
50. [50] Kim, J., Choi, J.Y., Park, S.-H., Yang, S.H., Park, J.A., Shin, K., et al. Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse. Arthritis Res. Ther. 16 (2014), 1–10.
51. [51] Podbregar, M., Lainscak, M., Prelovsek, O., Mars, T., Cytokine response of cultured skeletal muscle cells stimulated with proinflammatory factors depends on differentiation stage. Sci. World J., 2013, 2013, 8.
52. [52] Mundt, S., Basler, M., Buerger, S., Engler, H., Groettrup, M., Inhibiting the immunoproteasome exacerbates the pathogenesis of systemic Candida albicans infection in mice. Sci. Rep., 6, 2016, 19434.
53. [53] Opitz, E., Koch, A., Klingel, K., Schmidt, F., Prokop, S., Rahnefeld, A., et al. Impairment of immunoproteasome function by ?5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog, 7, 2011, e1002233.
54. [54] Kitamura, A., Maekawa, Y., Uehara, H., Izumi, K., Kawachi, I., Nishizawa, M., et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J. Clin. Investig. 121 (2011), 4150–4160.
55. [55] Arima, K., Kinoshita, A., Mishima, H., Kanazawa, N., Kaneko, T., Mizushima, T., et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc. Natl. Acad. Sci. 108 (2011), 14914–14919.